Research output per year
Research output per year
Personal profile
Research interests
Clinical trials in breast cancer especially in patients with triple negative disease, early-onset breast cancer, racial disparities.
Clinical interests
Medical Oncology, breast cancer, breast oncology
Fingerprint
Dive into the research topics where Foluso Ademuyiwa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis
Krishnamurthy, J., Luo, J., Suresh, R., Ademuyiwa, F., Rigden, C., Rearden, T., Clifton, K., Weilbaecher, K., Frith, A., Roshal, A., Tandra, P. K., Cherian, M., Summa, T., Haas, B., Thomas, S., Hernandez-Aya, L., Bergqvist, M., Peterson, L. & Ma, C. X., Dec 2022, In: npj Breast Cancer. 8, 1, 35.Research output: Contribution to journal › Article › peer-review
Open Access -
Call for action: expanding global access to hereditary cancer genetic testing
Bychkovsky, B., Rana, H. Q., Ademuyiwa, F., Plichta, J., Anderson, K., Nogueira-Rodrigues, A., Santa-Maria, C. A., Coffman, L. G., Marquez, C., Das, A., Taghian, A., Koeller, D. R., Sandoval, R. L., Park, B. H. & Dizon, D. S., Sep 2022, In: The Lancet Oncology. 23, 9, p. 1124-1126 3 p.Research output: Contribution to journal › Comment/debate
-
Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer
Davis, A., Gerratana, L., Clifton, K., Medford, A. J., Velimirovic, M., Hensing, W. L., Bucheit, L., Shah, A. N., D'Amico, P., Reduzzi, C., Zhang, Q., Dai, C. S., Denault, E. N., Bagegni, N. A., Opyrchal, M., Ademuyiwa, F. O., Bose, R., Gradishar, W. J., Behdad, A., Ma, C., & 2 others, Dec 2022, In: EBioMedicine. 86, 104316.Research output: Contribution to journal › Article › peer-review
Open Access -
Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer
Roy, S., Whitehead, T. D., Li, S., Ademuyiwa, F. O., Wahl, R. L., Dehdashti, F. & Shoghi, K. I., Jan 2022, In: European Journal of Nuclear Medicine and Molecular Imaging. 49, 2, p. 550-562 13 p.Research output: Contribution to journal › Article › peer-review
Open Access19 Scopus citations -
Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 49, 2, (550-562), 10.1007/s00259-021-05489-8)
Roy, S., Whitehead, T. D., Li, S., Ademuyiwa, F. O., Wahl, R. L., Dehdashti, F. & Shoghi, K. I., Jan 2022, In: European Journal of Nuclear Medicine and Molecular Imaging. 49, 2, p. 788 1 p.Research output: Contribution to journal › Comment/debate
Open Access